Rationale and Baseline Characteristics of PREVENT: A Second-Generation Intervention Trial in Subjects At-Risk (Prodromal) of Developing First-Episode Psychosis Evaluating Cognitive Behavior Therapy, Aripiprazole, and Placebo for the Prevention of Psychosis

Prediction of Psychosis in Adolescents and Young Adults at High Risk

(2010) Stephan Ruhrmann et al.   ARCHIVES OF GENERAL PSYCHIATRY

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

(2010) G. Paul Amminger et al.   ARCHIVES OF GENERAL PSYCHIATRY

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

(2010) Christoph U. Correll et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Randomized-controlled trials in people at ultra high risk of psychosis: A review of treatment effectiveness

(2010) Antonio Preti et al.   SCHIZOPHRENIA RESEARCH

Intervention in Individuals at Ultra-High Risk for Psychosis

(2009) Patrick D. McGorry et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of Aripiprazole on Insight and Subjective Experience in Individuals With an At-Risk Mental State

(2009) Hiroyuki Kobayashi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study

(2009) Scott W. Woods et al.   SCHIZOPHRENIA BULLETIN

Prediction of Psychosis in Youth at High Clinical Risk

(2008) Tyrone D. Cannon et al.   ARCHIVES OF GENERAL PSYCHIATRY

Subjective Symptoms of Schizophrenia in Research and the Clinic: The Basic Symptom Concept

(2008) F. Schultze-Lutter   SCHIZOPHRENIA BULLETIN